Blood cancers
Myelodysplastic syndrome (MDS)
We review blood counts, marrow and pathology reports and molecular results, then explain the diagnosis, the risk category and the care pathway.
What the consultation involves
- Your marrow and molecular reports are read together, not in isolation.
- We explain what risk category means in practice, and how it shapes the options.
- Monitoring, supportive care, treatment and transplant assessment are discussed as distinct paths.
Who may need this
- A marrow report suggesting dysplasia or a diagnosis of MDS
- Persistent low counts that have not responded to earlier treatment
- A second opinion on an existing MDS care plan
What to bring
- Bone marrow aspiration, biopsy and cytogenetic or molecular reports
- The full sequence of blood counts since the problem was first noticed
- Details of transfusions and treatments already received
Where care happens
Consultation at the centre, with treatment setting confirmed on a case-by-case basis.
Book an appointmentOr call +91 98679 67407Being confirmed
Confirm which treatments are given here and which partner hospital is used.